Prestige Consumer Healthcare Inc.
Company History
Prestige Consumer Healthcare History: Founding, Growth & Key Milestones
Founded 1996 in Tarrytown, New York, United States
When was Prestige Consumer Healthcare founded?
Prestige Consumer Healthcare was founded in 1996 in Tarrytown, New York, United States by Prestige Brands (predecessor businesses), making it 30 years old.
- Founded
- 1996
- Founding place
- Tarrytown, New York, United States
- Founders
- Prestige Brands (predecessor businesses)
- Headquarters today
- Tarrytown, New York
- Milestones documented
- 10 (2005–2026)
- Current CEO
- Ronald M. Lombardi
- Acquisitions
- 7
| Year | Event |
|---|---|
| 2005 | NYSE IPO |
| 2009 | Matthew Mannelly becomes CEO |
| 2010 | Blacksmith Brands Acquired |
| 2014 | Acquired Hydralyte |
| 2015 | Ron Lombardi Becomes CEO |
| 2021 | TheraTears Acquisition |
| 2025 | Acquired Pillar5 Pharma |
| 2026 | FY2026 Results |
| 2026 | Breathe Right Closed |
| 2026 | LaCorium Closed |
- Where was Prestige Consumer Healthcare founded?
- Prestige Consumer Healthcare was founded in Tarrytown, New York, United States in 1996.
- Who founded Prestige Consumer Healthcare?
- Prestige Consumer Healthcare was founded by Prestige Brands (predecessor businesses).
- When did Prestige Consumer Healthcare start?
- Prestige Consumer Healthcare was founded in 1996.
- How old is Prestige Consumer Healthcare?
- Prestige Consumer Healthcare is 30 years old as of 2026.
Founding Story
Prestige traces its roots to 1996, when its predecessor began assembling consumer brands. Private equity firm GTCR acquired the business in 2004, and Prestige Brands Holdings went public on the NYSE in February 2005. The early portfolio mixed OTC medicines, personal care and household cleaners such as Comet and Spic and Span. Over the following decade the company bought larger OTC portfolios, sold the household cleaning business and in 2018 renamed itself Prestige Consumer Healthcare to reflect its pure OTC focus.
Founders
Prestige Brands (predecessor businesses)
Prestige's predecessor began acquiring consumer brands in 1996. GTCR acquired the company in 2004 and took Prestige Brands Holdings public on the NYSE in February 2005. The business later renamed itself Prestige Consumer Healthcare in 2018. (Exact birth year remains publicly undisclosed).
Key Milestones
Matthew Mannelly becomes CEO
Matthew Mannelly became CEO of Prestige Consumer Healthcare in 2009. Led the 2012 GSK brand acquisition; succeeded by Ron Lombardi on June 1, 2015.
Source: en.wikipedia.orgBlacksmith Brands Acquired
Prestige Brands bought Blacksmith Brands, owner of Efferdent and Luden's, in 2010.
Source: en.wikipedia.orgRon Lombardi Becomes CEO
Ronald M. Lombardi became President and CEO after serving as CFO.
Source: ir.prestigebrands.comTheraTears Acquisition
Prestige bought Akorn's consumer health business, including TheraTears, for $230 million.
Source: en.wikipedia.orgFY2026 Results
Revenue fell 4.3% to $1.089 billion on Clear Eyes supply limits; free cash flow was $246.4 million.
Source: sec.govBreathe Right Closed
Prestige closed the $1.045 billion purchase of Breathe Right and other brands from Foundation Consumer Healthcare on June 15, 2026.
Source: globenewswire.comLaCorium Closed
Prestige closed the roughly $150 million LaCorium Health acquisition on July 1, 2026 and priced $400 million of senior notes.
Source: stocktitan.netMajor Acquisitions
17 OTC brands from GlaxoSmithKline
2012Added BC, Goody's, Ecotrin, Beano and other OTC brands, making healthcare the core of Prestige.
Hydralyte
2014Added an oral rehydration brand that anchors the Australian business.
C.B. Fleet Company
2017Added Fleet and Summer's Eve, expanding women's health and gastrointestinal categories.
Akorn consumer health business (TheraTears)
2021Expanded eye care alongside Clear Eyes.
Pillar5 Pharma
2025Bought a Clear Eyes manufacturer to secure eye care production capacity.
Breathe Right and other brands (Foundation Consumer Healthcare)
2026Added Breathe Right nasal strips plus Anbesol, Dimetapp and other brands with about $200 million of revenue; about $900 million net of expected tax benefits. Closed June 15, 2026.
LaCorium Health
2026Added an Australian therapeutic skin care business for about $150 million in cash. Closed July 1, 2026.
Keep researching Prestige Consumer Healthcare
Prestige Consumer Healthcare Company History FAQ
When was Prestige Consumer Healthcare founded?
Its predecessor dates to 1996. GTCR acquired the business in 2004, it went public on the NYSE in 2005, and it took the Prestige Consumer Healthcare name in 2018.
What are Prestige's major historical milestones?
Key steps include the 2005 IPO, the $660 million purchase of 17 GSK OTC brands in 2012, Insight Pharmaceuticals (Monistat) in 2014, DenTek in 2016, C.B. Fleet for $825 million in 2017, the 2018 rename, TheraTears in 2021, and Breathe Right and LaCorium in 2026.
Why did Prestige leave household cleaning?
Cleaning brands such as Comet and Spic and Span had lower margins and heavy private-label pressure, so Prestige sold them and concentrated on OTC healthcare.
How was Prestige Brands Holdings originally established in 1996?
Prestige Brands was founded in 1996 by private equity investors to acquire neglected, non-core consumer healthcare brands from large multinational pharmaceutical companies, applying focused marketing and efficient third-party outsourced manufacturing to revive brand profitability.
Why did Prestige completely divest its household cleaning products division in 2018?
In July 2018, Prestige sold its household cleaning products portfolio (including Comet and Spic and Span) to Yellow Wood Partners for $397 million, officially rebranding as "Prestige Consumer Healthcare Inc." to focus 100% on high-margin, recession-resilient over-the-counter (OTC) pharmaceuticals.
What was the landmark acquisition of Fleet Laboratories in 2017?
In January 2017, Prestige acquired C.B. Fleet Company for $825 million in cash. The acquisition brought iconic digestive health brands (Fleet enemas, Summer's Eve feminine care, and Norforms) into Prestige, creating the largest revenue-generating category in the company.
How did Prestige acquire Dramamine and Chloraseptic from Meda AB?
Prestige built its dominant position in cough and motion sickness through strategic tuck-ins, acquiring motion-sickness leader Dramamine in 2011 and sore-throat specialist Chloraseptic, transforming them into household category staples across North American pharmacies.
When did Prestige acquire the iconic Breathe Right nasal strips brand?
In December 2020, Prestige acquired the global rights to the Breathe Right nasal strip brand from GlaxoSmithKline (GSK) for $483 million, significantly expanding its international presence in Europe, Australia, and Canada.
Related Strategic History
Compare founding milestones and corporate evolution
Explore Prestige Consumer Healthcare
Core profile pages, founders and related research hubs for this company.